Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
276studies shown
Showing 85-96 of 276
Other study type icon
CompletedEUCTR 2007-003035-22

ACP-103 for Schizophrenia

This study is completed in France, in the United Kingdom, in Belgium, .... It is testing ACP-103 for Schizophrenia.

In Belgium
SchizophreniaOther
Countries
France, United Kingdom, Belgium, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01812642

Safety study of JNJ-37822681 in schizophrenia

This study is completed in Belgium, in Germany, in Russia, .... It is testing JNJ-37822681 for schizophrenia.

In Belgium
SchizophreniaDrugFrom 20 Years to 55 Years
Countries
Belgium, Germany, Russia, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Other study type icon
CompletedEUCTR 2009-018161-12

Extended-release Guanfacine Hydrochloride for ADHD

This study is completed in the United Kingdom, in Belgium, in Germany, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.

In Belgium
ADHDOther
Countries
United Kingdom, Belgium, Germany, ...
Sponsor
Shire Development Inc
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.